• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成年型肌强直性营养不良 1 型患者的健康相关生活质量:系统评价。

Health-Related Quality of Life in Patients with Adult-Onset Myotonic Dystrophy Type 1: A Systematic Review.

机构信息

Institute of Environmental Medicine, Karolinska Institutet, Nobels väg 13, 17177, Stockholm, Sweden.

ICON plc, Stockholm, Sweden.

出版信息

Patient. 2019 Aug;12(4):365-373. doi: 10.1007/s40271-019-00357-y.

DOI:10.1007/s40271-019-00357-y
PMID:30714084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6598969/
Abstract

BACKGROUND

Adult-onset myotonic dystrophy type 1 (DM1) is a chronic, multisystem disorder that leads to disability and premature death.

OBJECTIVES

The objective of our study was to conduct a systematic literature review of the health-related quality of life (HRQoL) of patients with DM1.

METHODS

We searched Embase, Web of Science, and PubMed for English language full-text articles reporting results from studies of HRQoL in patients with adult-onset DM1 published between 1 January 2000 and 21 February 2018. We excluded reviews, editorials, and studies reporting results for a sample with fewer than five patients (to allow for meaningful inference).

RESULTS

The search identified 266 unique publications. Of these, 231 were excluded following title and abstract screening and 16 after full-text review, leaving 19 articles for data synthesis. We found 15 articles measuring the HRQoL of patients with adult-onset DM1 using the 36-Item Short Form Health Survey (SF-36), six using the Individualized Neuromuscular Quality of Life Questionnaire (INQoL), and one using Cantril's Ladder. Available evidence shows that patient HRQoL is impaired in DM1, mainly due to compromised physical health, but also reveals that substantial heterogeneity exists in estimates across studies.

CONCLUSIONS

HRQoL in adult-onset DM1 has been extensively studied using the SF-36 and the INQoL, but current estimates are inconclusive, and little is known of the impact of the disease as measured using other instruments. Our data synthesis should help characterize the patient burden of DM1 and inform future studies of HRQoL in this indication.

摘要

背景

成人型肌强直性营养不良 1 型(DM1)是一种慢性、多系统疾病,可导致残疾和过早死亡。

目的

我们的研究旨在对 DM1 患者的健康相关生活质量(HRQoL)进行系统文献回顾。

方法

我们检索了 Embase、Web of Science 和 PubMed,以获取 2000 年 1 月 1 日至 2018 年 2 月 21 日期间发表的关于成年型 DM1 患者 HRQoL 研究的英文全文文章。我们排除了综述、社论和报告样本中患者少于 5 例(以便进行有意义的推断)的研究。

结果

搜索共确定了 266 篇独特的出版物。其中,231 篇在标题和摘要筛选后被排除,16 篇在全文审查后被排除,留下 19 篇文章进行数据综合。我们发现 15 篇文章使用 36 项简短健康调查问卷(SF-36)测量成年型 DM1 患者的 HRQoL,6 篇使用个体化神经肌肉生活质量问卷(INQoL),1 篇使用 Cantril 阶梯。现有证据表明,DM1 患者的 HRQoL 受损,主要是由于身体健康受损,但也表明研究之间的估计存在很大的异质性。

结论

使用 SF-36 和 INQoL 广泛研究了成年型 DM1 的 HRQoL,但目前的估计尚无定论,对于使用其他工具测量疾病的影响知之甚少。我们的数据综合应该有助于描述 DM1 患者的疾病负担,并为这一适应症的 HRQoL 未来研究提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d4/6598969/8c07245df113/40271_2019_357_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d4/6598969/38ddef05da70/40271_2019_357_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d4/6598969/b1b21b7df64f/40271_2019_357_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d4/6598969/5e44d0f01bcf/40271_2019_357_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d4/6598969/8c07245df113/40271_2019_357_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d4/6598969/38ddef05da70/40271_2019_357_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d4/6598969/b1b21b7df64f/40271_2019_357_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d4/6598969/5e44d0f01bcf/40271_2019_357_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d4/6598969/8c07245df113/40271_2019_357_Fig4_HTML.jpg

相似文献

1
Health-Related Quality of Life in Patients with Adult-Onset Myotonic Dystrophy Type 1: A Systematic Review.成年型肌强直性营养不良 1 型患者的健康相关生活质量:系统评价。
Patient. 2019 Aug;12(4):365-373. doi: 10.1007/s40271-019-00357-y.
2
Review of patient-reported outcome measures for use in myotonic dystrophy type 1 patients.用于1型强直性肌营养不良患者的患者报告结局指标综述。
Muscle Nerve. 2017 Jul;56(1):86-92. doi: 10.1002/mus.25469. Epub 2017 Mar 1.
3
Quality of life in patients with myotonic dystrophy type 2.2型强直性肌营养不良患者的生活质量
J Neurol Sci. 2016 Jun 15;365:158-61. doi: 10.1016/j.jns.2016.04.018. Epub 2016 Apr 16.
4
Prospective measurement of quality of life in myotonic dystrophy type 1.前瞻性测量 1 型肌强直性营养不良的生活质量。
Acta Neurol Scand. 2017 Dec;136(6):694-697. doi: 10.1111/ane.12788. Epub 2017 Jun 28.
5
Disease burden of myotonic dystrophy type 1.1 型肌强直性营养不良的疾病负担。
J Neurol. 2019 Apr;266(4):998-1006. doi: 10.1007/s00415-019-09228-w. Epub 2019 Feb 20.
6
Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study.1型强直性肌营养不良症的疾病认知:一项观察性横断面研究。
Orphanet J Rare Dis. 2016 Apr 4;11:34. doi: 10.1186/s13023-016-0417-z.
7
Health-related quality of life in patients with myotonic dystrophy type 1 and amyotrophic lateral sclerosis.1 型肌强直性营养不良和肌萎缩侧索硬化症患者的健康相关生活质量。
Acta Neurol Belg. 2010 Mar;110(1):71-7.
8
Dependent and paranoid personality patterns in myotonic dystrophy type 1.1 型肌强直性营养不良中依赖和偏执的人格模式。
Acta Neurol Scand. 2014 Apr;129(4):219-25. doi: 10.1111/ane.12173. Epub 2013 Sep 3.
9
A review of muscle- and performance-based assessment instruments in DM1.对1型糖尿病中基于肌肉和表现的评估工具的综述。
Muscle Nerve. 2017 Jul;56(1):78-85. doi: 10.1002/mus.25468. Epub 2017 Mar 1.
10
Uncovering health and social care needs among myotonic dystrophy patients: Utility of the Needs and Provisions Complexity Scale.揭示肌强直性营养不良患者的健康和社会护理需求:需求和规定复杂性量表的效用。
Acta Neurol Scand. 2019 Jun;139(6):526-532. doi: 10.1111/ane.13086. Epub 2019 Mar 25.

引用本文的文献

1
Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.肌强直性营养不良患者嗜睡(白天过度嗜睡)的精神兴奋剂。
Cochrane Database Syst Rev. 2024 Nov 18;11(11):CD003218. doi: 10.1002/14651858.CD003218.pub3.
2
Expert Insights from a Delphi-driven Neurologists' Panel: Real-world Mexiletine use in Patients with Myotonic Disorders in Italy.德尔菲法驱动的神经科专家小组的专业见解:意大利美西律在强直性肌营养不良症患者中的实际应用
J Neuromuscul Dis. 2024;11(2):411-423. doi: 10.3233/JND-230115.
3
Care for capabilities: Implementing the capability approach in rehabilitation of patients with neuromuscular diseases. Study protocol of the controlled before-after ReCap-NMD study.

本文引用的文献

1
222nd ENMC International Workshop:: Myotonic dystrophy, developing a European consortium for care and therapy, Naarden, The Netherlands, 1-2 July 2016.第222届ENMC国际研讨会:强直性肌营养不良症,建立欧洲护理与治疗联盟,荷兰纳尔登,2016年7月1 - 2日
Neuromuscul Disord. 2018 May;28(5):463-469. doi: 10.1016/j.nmd.2018.02.003. Epub 2018 Feb 12.
2
Myotonic dystrophy patient preferences in patient-reported outcome measures.强直性肌营养不良患者对患者报告结局指标的偏好
Muscle Nerve. 2018 Jan 12. doi: 10.1002/mus.26066.
3
Prospective measurement of quality of life in myotonic dystrophy type 1.
关注能力:在神经肌肉疾病患者康复中实施能力方法。前后对照ReCap-NMD研究的研究方案。
PLoS One. 2021 Dec 21;16(12):e0261475. doi: 10.1371/journal.pone.0261475. eCollection 2021.
4
Change over time in ability to perform activities of daily living in myotonic dystrophy type 1.进行性肌强直性营养不良 1 型日常生活活动能力的变化。
J Neurol. 2020 Nov;267(11):3235-3242. doi: 10.1007/s00415-020-09970-6. Epub 2020 Jun 15.
5
Understanding Symptoms in RYR1-Related Myopathies: A Mixed-Methods Analysis Based on Participants' Experience.理解 RYR1 相关肌病的症状:基于参与者经验的混合方法分析。
Patient. 2020 Aug;13(4):423-434. doi: 10.1007/s40271-020-00418-7.
6
A population-based measure of chronic disease severity for health planning and evaluation in the United States.一种基于人群的慢性病严重程度衡量指标,用于美国的卫生规划与评估。
AIMS Public Health. 2020 Feb 4;7(1):44-65. doi: 10.3934/publichealth.2020006. eCollection 2020.
前瞻性测量 1 型肌强直性营养不良的生活质量。
Acta Neurol Scand. 2017 Dec;136(6):694-697. doi: 10.1111/ane.12788. Epub 2017 Jun 28.
4
Effects of 1-month withdrawal of ventilatory support in hypercapnic myotonic dystrophy type 1.1 型肌强直性营养不良患者撤机 1 个月的效果。
Respirology. 2017 Oct;22(7):1416-1422. doi: 10.1111/resp.13068. Epub 2017 May 9.
5
Prevalence of myotonic dystrophy type 1 in adults in western Sweden.瑞典西部成年人中1型强直性肌营养不良症的患病率。
Neuromuscul Disord. 2017 Feb;27(2):159-162. doi: 10.1016/j.nmd.2016.12.005. Epub 2016 Dec 13.
6
Review of patient-reported outcome measures for use in myotonic dystrophy type 1 patients.用于1型强直性肌营养不良患者的患者报告结局指标综述。
Muscle Nerve. 2017 Jul;56(1):86-92. doi: 10.1002/mus.25469. Epub 2017 Mar 1.
7
Myotonic Dystrophy Type 1 Management and Therapeutics.1型强直性肌营养不良的管理与治疗
Curr Treat Options Neurol. 2016 Dec;18(12):52. doi: 10.1007/s11940-016-0434-1.
8
Five-year study of quality of life in myotonic dystrophy.强直性肌营养不良患者生活质量的五年研究。
Acta Neurol Scand. 2016 Nov;134(5):346-351. doi: 10.1111/ane.12549. Epub 2015 Dec 21.
9
Multidimensional aspects of pain in myotonic dystrophies.强直性肌营养不良症疼痛的多维度特征
Acta Myol. 2015 Dec;34(2-3):126-32.
10
Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study.1型强直性肌营养不良症的疾病认知:一项观察性横断面研究。
Orphanet J Rare Dis. 2016 Apr 4;11:34. doi: 10.1186/s13023-016-0417-z.